Federal award
INNOCRIN PHARMACEUTICALS, INC.
W81XWH1520019
Assistance
Obligated and Ceiling
- Obligated (net)
- $2,772,142.39
- Potential value
- —
- Current value
- —
- Gross positive obligations
- $3,103,023.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- INNOCRIN PHARMACEUTICALS, INC. · CV4DA3MZLNL8
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- —
- Awarding agency
- Department of Defense · sub-agency 2100 · office W81XWH
- Funding agency
- Department of Defense · sub-agency 2100
- Assistance listing (CFDA)
- CFDA 12.420
- FAIN
- W81XWH1520019
- Award type code
- 05
- Actions
- 7 · Apr 15, 2015 to Nov 8, 2019
- Why it is listed
- a program on the reviewed research-assistance allowlist (DoD, DOE or NASA from $10k, or eligible DHS research)
Action History7
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Nov 8, 2019 | FY2020 | P00005 | FX | −$71,671.61 | — |
| Apr 18, 2018 | FY2018 | P00004 | EX | $259,209.00 | — |
| Apr 18, 2018 | FY2018 | T00004 | EX | −$259,209.00 | — |
| Jun 5, 2017 | FY2017 | P00003 | B1 | $0.00 | — |
| Sep 6, 2016 | FY2016 | 0002 | FX | $885,024.00 | — |
| Jul 30, 2015 | FY2015 | 0001 | EX | $0.00 | — |
| Apr 15, 2015 | FY2015 | — | A1 | $1,958,790.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.